Navigation Links
Vioxx Not Safe Even For Short Term Use

Canadian researchers have found that Vioxx painkiller manufactured by Merck & Co would result in an increased risk of heart attack within two weeks after patients start taking the drug. // Statistics show that about 60 patients out of 239 elderly patients suffered from heart attacks within six to 13 days after they first started taking Vioxx. The study results are published in the Canadian Medical Association Journal. It was contrary to what Merck had previously told about the drug. It currently faces 11,500 Vioxx lawsuits. The company has been hit with three jury awards totaling $298.3 million, two of which involved short-term use of the painkiller. It is also associated with the death of a man who took the drug for a period of 30 days.

Linda Levesque, assistant professor of epidemiology at Queen's University in Kingston, Ontario said that it is highly dangerous for the first time users and they might suffer an attack in as little as two weeks. Merck is the fourth-biggest U.S. drug maker. It withdrew Vioxx in 2004 when the drug was proved to double the risk of heart attacks and strokes. It has set aside $970 million for legal costs and vows to fight each case rather than settle out of court. `Cases Easier to Win' Attorney Mark Lanier, the attorney for the drug company has already won two out of the three trials. Canadian researchers analyzed health records of 114,000 patients ages 66 and older who were prescribed painkillers, including Vioxx, Celebrex and ibuprofen. The study followed patients for about two and a half years, included 30,200 Vioxx users and 45,000 Celebrex users. Celebrex was not associated with any heart attacks but when patients started taking Vioxx it significantly increased the risk among patients. But it also diminished. But it is thought that the study would play a major role in contributing to making a better decision by the people.


'"/>




Page: 1

Related medicine news :

1. Increased Heart Attack Risk From Celebrex,Vioxx
2. Merck to pay $ 253.5 million to Vioxx victim family
3. Judgment In Favor Of Merck For Vioxx Drug
4. Could Long Tern Vioxx Users Suffer From Heart Attacks?
5. Doctor Grilled In Court For False Report About Vioxx Health Risk
6. Vioxx and Celebrex, now have alternatives
7. Merck in the Dock Due To Vioxx
8. A Stroke of Bad Luck for Vioxx
9. Arcoxia Slammed –Nothing Better Than Vioxx Says FD
10. Bad News for Short People
11. Painkillers Do Not Shorten Dying Patients Lives
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... During the last week of March, Chad Kawa, ... eligible individuals in the local community. , Colon cancer is the second leading ... colon cancer while it is small, confined and easier to treat. If you are ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up to 36% ... other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors ... finding more effective treatment options, the San Diego Gamma Knife Center offers ...
(Date:3/29/2017)... Atlanta, Georgia (PRWEB) , ... March 29, 2017 , ... ... Theresa Therilus, founder of Pet Protect Law that assists dog owners in ... will assist new owners in taking the natural next step to protect their new ...
(Date:3/29/2017)... ... ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER AS , BALTIMORE WOMEN’S CLASSIC ... as the official title sponsor of the Baltimore Women’s Classic, the largest all women’s ... will walk or run the course around the Baltimore Inner Harbor. Mercy has been ...
(Date:3/29/2017)... ... , ... Sublime Naturals and its founder, Kathy Heshelow, are big fans of ... used for thousands of years. , "The West has caught on, and has discovered ... to Use it For Your Wellness. Overcome Inflammation, Enemy of the Body. " ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... , March 30, 2017  Lannett Company, Inc. (NYSE: ... voluntarily made a $25 million payment against its existing ... payment, combined with the $75 million payment we made ... $5.5 million in annualized cash interest expense, at current ... of Lannett.  "Our business is solid and we continue ...
(Date:3/30/2017)... Mar 30, 2017 Research and Markets ... Dialysis Market Size & Forecast, By Type (Hemodialysis, Peritoneal Dialysis), ... Trend Analysis From 2014 To 2025" report to their ... ... to reach USD 108.5 billion by 2025. ...
(Date:3/29/2017)... , March 29, 2017  Bodycad announced ... Drug Administration (FDA) 510(k) clearance for its Bodycad ... this truly personalized orthopaedic restoration. Bodycad is the ... a joint reconstruction implant system. ... optimize personalized restoration of the patient,s unique anatomical ...
Breaking Medicine Technology: